ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Interventional Cardiology

Top Interventional Cardiology Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
OVAIS RAZA MD, FACC

Interventional Cardiology

11,425

$501K

658
557 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $59

SHASHIDHAR DIVAKARUNI M.D.

Interventional Cardiology

7,612

$499K

651
600 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 26%

$66
Average prescription price

Avg: $59

SATYAM TATINENI M.D.

Interventional Cardiology

7,396

$347K

622
534 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $59

WILLIAM LEHMKUHLER MD

Interventional Cardiology

7,043

$320K

690
600 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $59

JOSHUA LEONARD MD

Interventional Cardiology

6,706

$201K

546
456 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 26%

$30
Average prescription price

Avg: $59

FRANK PAMELIA M.D.

Interventional Cardiology

6,454

$297K

562
486 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $59

ANURADHA DIVAKARUNI M.D.

Interventional Cardiology

6,406

$387K

560
508 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $59

STANLEY RICH M.D.

Interventional Cardiology

6,312

$414K

560
511 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$66
Average prescription price

Avg: $59

HORACE HICKMAN M.D., J.D.

Interventional Cardiology

5,946

$392K

414
366 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 26%

$66
Average prescription price

Avg: $59

ERIC SCHULTE MD

Interventional Cardiology

5,804

$309K

415
386 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $59

SRINIVASARAO MANCHIKALAPUDI MD

Interventional Cardiology

5,707

$235K

608
481 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 26%

$41
Average prescription price

Avg: $59

WILLIAM BERG M.D.

Interventional Cardiology

5,692

$386K

488
424 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $59

JAMES FIX

Interventional Cardiology

5,561

$314K

378
309 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $59

JAY SCHLAIFER MD

Interventional Cardiology

5,484

$309K

378
327 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $59

MCKINDRA FLETCHER M.D.

Interventional Cardiology

5,116

$227K

537
486 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $59

SAMMI DALI MD

Interventional Cardiology

4,643

$302K

394
295 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $59

MARK MEIER M.D.

Interventional Cardiology

4,339

$268K

380
326 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $59

MICHAEL HOGAN M.D.

Interventional Cardiology

4,333

$210K

435
371 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $59

ROBERT STARRETT M.D.

Interventional Cardiology

4,273

$269K

470
391 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $59

MICHAEL BALL MD

Interventional Cardiology

4,256

$417K

526
466 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 26%

$98
Average prescription price

Avg: $59

WOODROW COREY MD

Interventional Cardiology

4,220

$315K

360
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 26%

$75
Average prescription price

Avg: $59

KINGSLEY ANNAN MD

Interventional Cardiology

4,209

$233K

444
367 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $59

MICHAEL NICHOLAS DO

Interventional Cardiology

4,161

$334K

382
340 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 26%

$80
Average prescription price

Avg: $59

GEORGE BRODELL M.D.

Interventional Cardiology

4,127

$236K

371
320 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $59

CARL ROUCH M.D.

Interventional Cardiology

4,058

$263K

361
309 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $59

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank